Home treatment with subcutaneous immunoglobulin infusion to children with primary immunodeficiency disease; the role of the nurse

被引：0
作者：
Halvorsen, K. [1 ]
Sandersen, H. [1 ]
Lynum, M. B. [1 ]
Abrahamsen, T. G. [1 ,2 ]
机构：
[1] Rikshosp Univ Hosp, Div Paediat, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2008年 / 154卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [42] Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease
    Patel, Niraj C.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (06) : 583 - 588
  • [43] IMPROVEMENT IN TREATMENT SATISFACTION AMONG PRIMARY IMMUNODEFICIENCY PATIENTS ON AN INVESTIGATIONAL 20 % SUBCUTANEOUS IMMUNOGLOBULIN THERAPY
    Meckley, Lisa
    Ito, Diane
    Hu, Xingdi
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 245 - 245
  • [44] Treatment Satisfaction Upon Switching To Flexibly-dosed Subcutaneous Immunoglobulin G In Primary Immunodeficiency
    Jones, Claire
    Noorani, Sadia
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 2 - 2
  • [45] Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig(R) [octanorm])
    Kobayashi, Roger H.
    Mandujano, Jose Fernando
    Rehman, Syed M.
    Kobayashi, Ai Lan
    Geng, Bob
    Atkinson, Thomas Prescott
    Melamed, Isaac
    Turpel-Kantor, Eva
    Clodi, Elisabeth
    Gupta, Sudhir
    IMMUNOTHERAPY, 2021, 13 (10) : 813 - 824
  • [46] Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic review
    Anderson-Smits, Colin
    Park, Michelle
    Bell, Judith
    Mitchell, Sarah
    Hartley, Louise
    Hawe, Emma
    IMMUNOTHERAPY, 2022, 14 (05) : 373 - 387
  • [47] FROM CLINICAL TRIAL TO REAL-WORLD USE: SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) 20% INFUSION IN PRIMARY IMMUNODEFICIENCY DISORDERS
    Carne, E.
    Panahloo, Z.
    Barber, S.
    Morris, K.
    El-Shanawany, T.
    Jolles, S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 167 - 167
  • [48] Experience with a 20% Subcutaneous Immunoglobulin (Hizentra®) in Children with Primary Immunodeficiency Diseases - A Single-Center Review
    Gregory, Rebecca
    Malcolmson, Clare
    Patel, Chetan
    Woolley, Terry
    Jones, Alison
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB154 - AB154
  • [49] Interim Analysis of Infusion Characteristics and Adverse Events During Facilitated Subcutaneous Immunoglobulin Treatment for Primary Immunodeficiency Diseases: Global Post Authorization Safety Study
    Rubinstein, Arye
    Bridges, Tracy
    Wedner, H. James
    McNeil, Donald
    Wasserman, Richard L.
    Tachdjian, Raffi
    Fielhauer, Katharina
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S53 - S54
  • [50] Diagnosis and treatment of primary immunodeficiency disease: the role of the otolaryngologist
    Wasserman, Richard L.
    Manning, Scott C.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2011, 32 (04) : 329 - 337
12345